According to Dr. Weigert, Breast-Specific Gamma Imaging is a valuable technology that can help to diagnose unsuspected cancers and find greater extent of disease than may have been identified with mammography and ultrasound alone.
About BSGI with the Dilon 6800 Gamma Camera
Breast-Specific Gamma Imaging (BSGI) performed with the Dilon 6800, is a molecular breast imaging technique that can see lesions independent of tissue density and discover very early stage cancers. BSGI serves as a complementary diagnostic adjunct procedure to mammography and ultrasound for difficult-to-diagnose patients. With BSGI, the patient receives a radioactive tracing agent that is absorbed by all the cells in the body. Cancerous cells in the breast, due to their increased rate of metabolic activity, absorb a greater amount of the tracing agent than normal, healthy cells and generally appear as "hot spots" on the BSGI image.
BSGI is ideal for patients with mammograms that are difficult to interpret due to a variety of factors, such as: dense breast tissue, suspicious areas on a mammogram, lumps that can be felt but not seen with mammography or ultrasound, implants and breast augmentation, scarring from previous surgeries and for women with an increased risk of breast cancer diagnosis.
About Dilon Technologies
Dilon Technologies is bringing innovative new medical imaging products
to market. Dilon's cornerstone product, the Dilon 6800, is a
high-resolution, small field-of-view gamma camera, optimized to perform
Breast-Specific Gamma Imaging (BSGI), a molecular breast imaging procedure
that images the metabolic activity of breast lesions through radiotracer
uptake. Many leading medical centers around the country are now offering
BSGI to their patients, including: Cornell University Medical Center, New
York; George Washington University Medical Center, Washington, D.C.;
Northwestern Memorial Hospital, Chicago; a
|SOURCE Dilon Technologies|
Copyright©2007 PR Newswire.
All rights reserved